LIFE WITH MYELOMA - June 17, 2021
There's additional risk of developing atrial fibrillation (AF) for patients with certain types of cancers including multiple myeloma, according to Kore... Read More
Statistically, multiple myeloma is more prevalent in the older population. Age alone brings about many changes in health. A diagnosis and treatment ... Read More
Understanding your Minimal Residual Disease status, and understanding what MRD testing is and what it means is critical to the future of myeloma and your myelom... Read More
UPCOMING MC ROUND TABLES - June 16, 2021
Six Myeloma Experts Discuss ASCO/EHA Studies Register Now The annual meetings of the American Society of Clinical Oncology (ASCO) and ... Read More
MYELOMA NEWS - June 15, 2021
In a prior article, we shared that a new off-the-shelf bispecific antibody targeting BCMA by Janssen (teclistimab) just received Breakthrough Therapy Desig... Read More
LIFE WITH MYELOMA - June 15, 2021
What Is MRD? Minimal residual disease (MRD), sometimes called measurable residual disease, refers to a measurement of myeloma cells that remain after treatm... Read More
MYELOMA NEWS - June 14, 2021
It is hard to keep up with the recent developments of CAR-T products used in relapsed/refractory multiple myeloma (RRMM) patients, but an exciting new CAR-... Read More
LIFE WITH MYELOMA - June 12, 2021
Multiple myeloma is more prevalent in the older population; the median age of diagnosis is 69 years, and 35% of patients are age 75 or older at diagnosis.1 ... Read More
LIFE WITH MYELOMA - June 10, 2021
According to Chinese myeloma researchers, the global incidence of multiple myeloma has more than doubled globally since 1990. In a study, data from the 201... Read More
MC RADIO - June 09, 2021
Peter Voorhees, MD Levine Cancer Institute - Atrium Health Interview Date: May 18, 2021 Thanks to our episode sponsor Summary Quad therapies (fou... Read More
MYELOMA NEWS - June 06, 2021
Teclistamab, an off-the shelf bispecific antibody targeting BCMA by Janssen, has received Breakthrough Therapy Designation from the FDA. This designation f... Read More
MYELOMA NEWS - June 04, 2021
What is "salvage therapy"? The Dictionary of the National Cancer Institute defines “Salvage Therapy” as “Treatment that is give... Read More
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
MYELOMA TREATMENTS and CLINICAL TRIALS
Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.
We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.